Thank you to the American Brain Tumor Association for coordinating their 50th Annual Conference. This event provided us with an invaluable platform to engage with individuals enduring the challenges of brain tumors, including patients, dedicated caregivers, and the families of those affected. By participating in this conference, we gained profound insights into the lives of those affected by brain tumors, allowing us to enhance our ability to better support patients with this disease.
Biocept, Inc.
Biotechnology Research
San Diego, California 5,556 followers
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions.
Über uns
Biocept, Inc. (Nasdaq: BIOC) develops and performs clinical laboratory tests to help patients with cancer that has metastasized to the central nervous system (CNS). Our CNSide™ assay provides enhanced detection and analysis of tumor cells and cell-free DNA from cerebrospinal fluid (CSF). Quantitative results help evaluate a patient’s response to treatment. Additional biomarkers can characterize genetic changes associated with therapy resistance and identify new options for treating CNS metastasis. CNSide results from Biocept’s CLIA-certified and CAP-accredited laboratory help oncologists manage one of the most difficult complications of cancer, answering three critical questions: Is there tumor in the CSF? Is there a target for treatment? Is there a trend in treatment response? The Biocept team is dedicated to improving care for cancer patients – which means making a difference in people’s lives, every day. Biocept also provides RT-PCR based COVID-19 testing to support state and national public health efforts.
- Website
-
http://www.biocept.com
External link for Biocept, Inc.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- San Diego, California
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1993
- Spezialitäten
- Oncology Testing, CTC Testing, ctDNA, laboratory testing, cancer diagnostics, clinical testing, liquid biopsy, clinical services, diagnostic products, testing services, cancer diagnostic development, metastatic breast cancer, non-small cell lung cancer, prostate cancer, colorectal cancer, melanoma, gastric cancer, and molecular testing
Standorte
-
Primäre
9955 Mesa Rim Road
San Diego, California 92121, US
Employees at Biocept, Inc.
-
Ivor Royston
Executive Chairman, Board Member, and Entrepreneur
-
Randy Goodman, PhD, MHA, BA, FACHE
Principal: Health Economics and Outcomes Research, Real World Data, Real World Evidence at Skysis LLC, a Fishawack Health Company
-
Linda Macander
Executive Assistant to CEO at Biocept
-
Janet Torio
Retired! Not seeking employment!
Aktualisierungen
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 5.0M